NOMAD POWER SOLUTIONS, INC. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
NOMAD POWER SOLUTIONS, INC. (NMAD) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $1.94 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-31
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.94M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.55M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.63M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $2.14M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2025-12-31 | $1.94M 10-K · filed 2026-03-31 |
| 2024-12-31 | $1.55M 10-K · filed 2026-03-31 |
| 2023-12-31 | $1.63M 10-K · filed 2025-03-24 |
| 2022-12-31 | $2.14M 10-K · filed 2024-03-19 |
| 2021-12-31 | $1.82M 10-K · filed 2023-03-29 |
| 2020-12-31 | $1.11M 10-K · filed 2022-03-21 |
| 2019-12-31 | $799.00K 10-K · filed 2021-03-26 |
| 2018-12-31 | $626.00K 10-K · filed 2020-03-25 |
| 2017-12-31 | $407.00K 10-K · filed 2019-03-25 |
| 2016-12-31 | $860.00K 10-K · filed 2018-03-23 |
| 2015-12-31 | $938.00K 10-K · filed 2017-03-29 |
| 2014-12-31 | $952.00K 10-K · filed 2016-03-28 |
| 2013-12-31 | $750.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |